Novel Therapies for ATTR; An Introduction to CRISPR-Cas9 In Vivo Gene Editing
Dr. Julian Gillmore from the National Amyloid Centre, UK, presents "Novel Therapies for ATTR; An Introduction to CRISPR-Cas9 In Vivo Gene Editing" at Amyloid Day in Calgary 2022.